EGFR Mutant NSCLC Post Osimertinib - The International Association for the Study of Lung Cancer

EGFR Mutant NSCLC Post Osimertinib

Podcast | English | 31 Min

Create Account

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists, Dr. Xiuning Le and Dr. Hidehito Horinouchi, both global experts in targeted therapy.

Dr. Stephen Liu
Dr. Xiuning Le
Dr. Hidehito Horinouchi